跳至主要内容
临床试验/NCT03861975
NCT03861975进行中(未招募)不适用

Exploring the Efficacy and Feasibility of the LymphaTech Scanner for Breast Cancer-Related Lymphedema Screening

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2019年1月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
100
试验地点
2
主要终点
Precision and reliability

研究概览

简要总结

This research will compare the absolute volumes of the upper extremity using both the LymphaTech Scanner and Perometer in a cohort of patients with a history of invasive or in-situ carcinoma of the breast.

详细描述

Our trial seeks to assess the efficacy of the LymphaTech Scanner as compared to the Perometer, which is currently used to screen for breast cancer-related lymphedema. The focus of the study is to compare the absolute volumes of the upper-extremity as measured by each device and to compare the time it takes to measure both arms of a patient using each device to assess clinical feasibility.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Participants must have histologically or cytologically confirmed invasive or in-situ carcinoma of the breast and will undergo unilateral breast cancer surgery
  • Age >18 years.
  • Ability to understand and the willingness to verbally consent to the trial

排除标准

  • History of primary lymphedema.
  • Any patient with a current case of cellulitis.
  • Participants with known brain metastases should be excluded from this clinical trial because of their poor prognosis and because they often develop progressive neurologic dysfunction that would confound the evaluation of neurologic and other adverse events.
  • Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.
  • Participants unable to abduct upper-extremity perpendicular to body or to stand comfortably without aid for several minutes, both of which are necessary to perform a LymphaTech Scan

研究组 & 干预措施

Breast Cancer-Related Lymphedema Measurements

Experimental

Absolute volume of the upper extremities will be assessed using the LymphaTech Scanner and the Perometer.

干预措施: Breast Cancer-Related Lymphedema Measurements (Other)

结局指标

主要结局

Precision and reliability

时间窗: 3 years

To determine whether the LymphaTech scanner is a precise and reliable tool for measuring upper extremity volume changes in patients treated for breast

次要结局

  • Measurement Time(3 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alphonse Taghian

Principal Investigator

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验

Exploring the Efficacy and Feasibility of the... | 临床试验